Peter Thiel

As companies scale, the original vision can become diluted. Innovation is often sacrificed for bureaucracy, and the entrepreneurial spirit is replaced by a risk-averse mentality. This stifles creativity and can lead to stagnation.

As an advocate for technological innovation, I strongly believe we should permit people to extend their lives through experimental longevity treatments. Advancements in biotechnology hold immense potential for improving human health and lifespan. Denying access to these treatments would hinder progress and prevent us from unlocking new possibilities for the future of humanity.

While personal development is valuable, I believe that focusing solely on self-improvement without addressing systemic issues and innovation does not automatically contribute to a better global society. We also need to drive forward collective efforts and technological advancements that can address broader problems on a global scale.